Product image of Lacosamida Opko (Lacosamide) supplied by GNH India

Lacosamida Opko

Active Ingredient:
Lacosamide
Origin:
EU

Lacosamida Opko (Lacosamide)

Lacosamide, the active ingredient in Lacosamida Opko, is a sodium channel blocker presented as a tablet for oral use. It is used to treat focal seizures in patients with epilepsy.

GNH India supplies Lacosamida Opko as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Opko Health Spain Slu

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lacosamide is an antiepileptic drug that targets neuronal hyperexcitability in focal seizure disorders.

  • Focal seizures: reduces seizure frequency in patients with focal epilepsy.
  • Partial‑onset seizures: provides adjunctive control when other therapies are insufficient.
  • Adjunctive therapy for epilepsy: used together with other antiepileptics to improve overall seizure management.

How It Works

  • Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, stabilizing neuronal membranes and decreasing repetitive neuronal firing. By selectively targeting the slow inactivation phase, it reduces hyperexcitability without markedly affecting normal neuronal conduction, contributing to seizure control in focal epilepsy.

Side Effects

Lacosamide may cause a range of adverse reactions, from mild to serious.

Common Side Effects

  • Dizziness: transient light‑headedness, especially after dose initiation.
  • Fatigue: feeling unusually tired or low‑energy.
  • Nausea: mild stomach upset or queasiness.
  • Headache: pressure or throbbing pain in the head.
  • Diplopia: occasional double vision.
  • Somnolence: increased sleepiness during the day.

Serious or Rare Side Effects

  • Suicidal thoughts: emergence of depressive symptoms or suicidal ideation.
  • Severe skin reactions: rare cases of Stevens‑Johnson syndrome or toxic epidermal necrolysis.
  • Cardiac arrhythmia: potential PR‑interval prolongation.
  • Liver enzyme elevation: abnormal hepatic function tests.
  • Hypersensitivity: rash, swelling, or anaphylactic signs.
  • Blood dyscrasias: rare reports of agranulocytosis or thrombocytopenia.

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Renal impairment: assess renal function and monitor for accumulation.
  • Hepatic impairment: use with caution and monitor liver enzymes.
  • Pregnancy: risk category unknown; discuss potential benefits and risks with a healthcare professional.
  • Concomitant CNS depressants: monitor for additive sedation or respiratory depression.
  • Suicidal ideation: observe mood changes and report any thoughts of self‑harm.
  • Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Lacosamide can interact with several medicines; some require avoidance while others need careful monitoring.

Major Interactions (Avoid)

  • Carbamazepine: induces metabolism, lowering lacosamide plasma levels.
  • Phenytoin: reduces lacosamide exposure through enzyme induction.
  • Rifampin: decreases lacosamide concentrations via hepatic enzyme induction.

Moderate Interactions (Monitor Closely)

  • CNS depressants (e.g., benzodiazepines): may increase sedation and respiratory depression.
  • Alcohol: can enhance dizziness and drowsiness.
  • Antidepressants (e.g., SSRIs): monitor for potential QT‑interval prolongation.

Frequently Asked Questions

Lacosamida Opko contains lacosamide, an antiepileptic medication indicated for the treatment of focal (partial‑onset) seizures. It is prescribed as adjunctive therapy in patients with epilepsy when seizure control is not achieved with other agents.

Lacosamide enhances the slow inactivation of voltage‑gated sodium channels in neurons. This stabilizes the neuronal membrane, reduces repetitive firing, and diminishes the hyperexcitability that leads to seizure activity, particularly in focal epilepsy.

The dosage of Lacosamida Opko is individualized by the prescribing clinician based on the patient’s age, weight, renal function, and response to therapy. The prescriber determines the appropriate starting dose and titration schedule.

The pregnancy safety category for lacosamide is not definitively established. It should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. Lactating mothers should consult their healthcare provider, as it is excreted in breast milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Lacosamide is distinct for its selective enhancement of slow sodium‑channel inactivation, offering a different mechanism compared with traditional sodium‑channel blockers like carbamazepine. This can provide effective seizure control with a potentially different side‑effect profile, making it a valuable option when other agents are insufficient.

Lacosamida Opko tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

The medication is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

Serious risks include the emergence of suicidal thoughts or behaviors, severe skin reactions such as Stevens‑Johnson syndrome, cardiac conduction abnormalities (e.g., PR‑interval prolongation), and rare blood disorders. Patients should be monitored closely for these events.

Patients with known hypersensitivity to lacosamide or any of the tablet excipients should avoid the product. Caution is also advised for individuals with significant cardiac conduction disorders, severe renal or hepatic impairment, and those taking interacting medications that may reduce efficacy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lacosamide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT